Bevacizumab in the treatment of nonsquamous non-small cell lung cancer: clinical trial evidence and experience.
about
Clinical response to apatinib monotherapy in advanced non-small cell lung cancer.Evaluation of efficacy and safety for bevacizumab in treating malignant pleural effusions caused by lung cancer through intrapleural injection.Incidence and risk of thromboembolism associated with bevacizumab in patients with non-small cell lung carcinoma
P2860
Bevacizumab in the treatment of nonsquamous non-small cell lung cancer: clinical trial evidence and experience.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Bevacizumab in the treatment o ...... trial evidence and experience.
@en
type
label
Bevacizumab in the treatment o ...... trial evidence and experience.
@en
prefLabel
Bevacizumab in the treatment o ...... trial evidence and experience.
@en
P2093
P2860
P921
P356
P1476
Bevacizumab in the treatment o ...... trial evidence and experience.
@en
P2093
Fabrice Barlesi
Laurent Greillier
Pascale Tomasini
P2860
P304
P356
10.1177/1753465816652083
P5008
P577
2016-06-23T00:00:00Z
2016-10-01T00:00:00Z